Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Piramal Pharma Limited
PPLPHARMA | NSE
150.81
INR2.02
1.36%
PPLPHARMA | NSE
Loading StockChartView...
About Piramal Pharma Limited
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/03/2024
As of date
21/04/2026
Close
150.81
Open
149.00
High
151.99
Low
148.90
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products as well as provides various pharma services including injection HPAPI etc. The company was incorporated in 2020 and is based in Mumbai India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
View LessPPLPHARMA | NSE
Risk
35.9
Sharpe
-1.12
Luna's Score
52/100
Recommendation
Hold
Luna says (PPLPHARMA | NSE)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Midcap (2B - 10B USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
16.5%1 month
35.9%3 months
35.2%6 months
30.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
805.68
Fwd. PE
-
Price to book
3.88
Debt to equity
0.60
Debt to assets
0.31
Ent. to EBITDA
24.44
Ent. to rev.
4.20
PEG
-
Other Fundamentals
EBITDA
12.15B
MarketCap
199.37B
MarketCap(USD)
2.13B
Div. yield
0.05
Op. margin
1.02
Erngs. growth
83.30
Rev. growth
11.60
Ret. on equity
0.24
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
12.19
Range1M
19.69
Range3M
37.24
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.74
Price X volume
346.69M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 24.44 | 54.00 | Cheaper |
| Ent. to Revenue | 4.20 | 7.68 | Cheaper |
| PE Ratio | 805.68 | 53.67 | Expensive |
| Price to Book | 3.88 | 6.76 | Cheaper |
| Dividend Yield | 0.05 | 0.26 | Poor |
| Std. Deviation (3M) | 35.23 | 50.01 | Lower Risk |
| Debt to Equity | 0.60 | -0.16 | Expensive |
| Debt to Assets | 0.31 | 0.17 | Expensive |
| Market Cap | 199.37B | 129.43B | Market Leader |
